HIV-infected patients | |||||
---|---|---|---|---|---|
Control group | Non-HCV co-infected group | HCV co-infected group | |||
( n = 102) | VL < 40 copies/mL | VL > 40 copies/mL | VL < 40 copies/mL | VL > 40 copies/mL | |
(n = 47) | (n = 29) | (n = 67) | (n = 48) | ||
FASN, μg/L | 3.36 (0.92) | 5.83 (1.34) a | 5.08 (1.74) * | 12.69 (2.01) c | 14.41 (2.91) c |
NEFA, mmol/L | 0.65 (0.04) | 0.62 (0.06) | 0.64 (0.06) | 0.63 (0.04) | 0.61 (0.05) |
Glucose, mmol/L | 4.96 (0.16) | 5.61 (0.20) c | 5.2 (0.14) b | 5.42 (0.12) c | 5.16 (0.10) b |
Insulin, pmol/L | 64.6 (6.59) | 69.22 (9.68) | 47.95 (6.11) a,* | 84.40 (10.79) a | 76.31 (11.82) |
HOMA-IR | 1.15 (0.20) | 1.33 (0.18) | 0.92 (0.14) a,* | 1.64 (0.22) a | 1.48 (0.25) |
Cholesterol, mmol/L | 5.27 (0.12) | 5.52 (0.19) | 5.14 (0.23) | 4.74 (0.15) c | 4.41 (0.16) c |
HDL-cholesterol, mmol/L | 1.36 (0.03) | 1.24 (0.09) a | 1.15 (0.08) b | 1.21 (0.05) b | 1.07 (0.05) c, * |
LDL-cholesterol, mmol/L | 3.19 (0.79) | 3.28 (0.17) | 2.96 (0.17) | 2.71 (0.13) c | 2.38 (0.13) c |
Triglyceride, mmol/L | 1.27 (0.9) | 3.00 (0.47) c | 3.11 (1.01) | 2.04 (0.18) c | 3.24 (1.09) c |
Apolipoprotein AI, g/L | 1.69 (0.05) | 1.44 (0.05) c | 1.26 (0.04) c, ** | 1.40 (0.03) c | 1.33 (0.04) c |
Alanine aminotransferase, μKat/L | 0.46 (0.02) | 0.45 (0.03) | 0.51 (0.04) | 0.98 (0.11) c | 0.97 (0.11) c |
Aspartate aminotransferase, μKat/L | 0.41 (0.02) | 0.41 (0.03) | 0.47 (0.08) | 0.88 (0.09) c | 0.88 (0.99) c |